Vietnam

Most local pharma firms hold the research on new drugs as their predominant strategy.

The goal is to tap into the country’s growing pharmaceutical market.

Policyholders can access English and Vietnamese consultations through mobile phones.

The plan to cover the health insurances of 84% of the population could drive investment growth.

Out-of-pocket spending is dominating healthcare financing.

The biggest challenge for Vietnam’s leading healthcare companies in the coming years is to figure out how to build a manufacturing base in the country, despite a wobbly operating environment.